Minirin (Desmopressin Acetate Trihydrate)

Desmopressin, the active ingredient in Minirin, is a vasopressin analog presented as an oral tablet for oral use. It replaces antidiuretic hormone activity and is used to manage central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders in adults and children.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to reduce excessive urine output and improve hemostasis.

- Central diabetes insipidus: restores water balance by decreasing urine volume. - Nocturnal enuresis: reduces nighttime bedwetting episodes in children and adolescents. - Mild hemophilia A: enhances clot formation by raising plasma factor VIII levels. - Von Willebrand disease: improves platelet adhesion and reduces bleeding tendency.

Desmopressin may cause a range of adverse reactions, from mild to serious. Patients should be aware of common and rare events.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal congestion: sensation of blocked nose. - Nausea: occasional upset stomach. - Hyponatraemia: low blood sodium, especially with excess fluid intake. - Flushing: transient warmth or redness of skin.

Serious or Rare Side Effects: - Severe hyponatraemia with seizures or coma. - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Allergic reactions: rash, itching, or swelling. - Cardiac arrhythmias: irregular heartbeat in susceptible individuals. - Water intoxication: rapid weight gain and confusion.

Before initiating therapy, clinicians should evaluate patient history and monitor relevant parameters.

- Assess fluid balance: avoid excessive water intake to prevent hyponatraemia. - Monitor electrolytes: check serum sodium regularly, especially in the elderly. - Evaluate renal function: adjust use in patients with impaired kidney function. - Review bleeding risk: consider underlying coagulopathies before use. - Pregnancy and lactation: use only if benefits outweigh potential risks; data are limited. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Desmopressin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): increase risk of hyponatraemia. - Diuretics (especially thiazides): potentiate water retention and electrolyte disturbances. - Anticoagulants (e.g., warfarin): may enhance bleeding risk when used for hemostasis.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): additive effect on serum sodium levels. - CYP450 substrates: limited effect, but monitor for unexpected changes. - Alcohol: may exacerbate hyponatraemia and dizziness.